Abstract Library

#4169 Germline mutation spectrum of neuroendocrine tumors

Introduction: Neuroendocrine tumors (NETs) are rare and highly heterogeneous tumors. Some specific hereditary syndromes enhance the incidence of NETs, suggesting that germline variation may contribute to neuroendocrine tumorigenesis. However, germline genetic variants in Chinese NET patients remain unclear.

Conference:

Presenting Author:

Authors: Sun Y, Tan H, Dong L, Jiang L, Zhao H,

Keywords: germline mutation, neuroendocrine tumor, genetic,

#4102 The quantitative assessment importance in NETs diagnosis

Introduction: SRS are representing the gold standard in SRS overexpression NETs diagnosis.

Conference:

Presenting Author:

Authors: Stolniceanu C, Grierosu I, Preda C, Ungureanu C, Tibu R,

Keywords: SRS, neuroendocrine tumor,

#2876 Efficacy of Surufatinib in Western Patients (pts) with Pancreatic Neuroendocrine Tumors (PanNETs)

Introduction: Surufatinib is a targeted inhibitor of tyrosine kinases VEGFR1, 2, & 3, FGFR1, and CSF-1R. The safety profile was favorable in 2 completed studies (NCT02133157, NCT02267967) conducted in China. A recent phase 3 placebo controlled study (NCT02588170) confirmed safety, and demonstrated superior efficacy (PFS: 9.2 v 3.8 months) of Surufatinib in Chinese pts with advanced extra-pancreatic NETs (epNET).

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Dasari A, Paulson S, Sung M, Tucci C, Kauh J,

Keywords: Neuroendocrine Tumors, Pancreatic, Surufatinib,

#2838 Accidental Injection of Unlabeled Lu-177 Caused Catastrophic Consequences in Patients with Neuroendocrine Tumor

Introduction: Since Lu-177 DOTATATE treatment is not approved in South Korea, patients with neuroendocrine tumors were sent to Germany and Malaysia for the treatment.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Kang K, Song Y, Kwon T, Ha W, Jin Y,

Keywords: radiation accident, PRRT, neuroendocrine tumor,

#655 Enucleation of Pancreatic Neuroendocrine Neoplasms Combined with Pre-Operative Wirsung Stenting, Intra-Operative Ultrasounds and Absorbable Fibrin Sealant Patch Application.

Introduction: Parenchyma-sparing surgery is indicated in small pancreatic neuroendocrine neoplasms (pNENs), however, it is often followed by high morbidity rates.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Zerbi A

Authors: Gavazzi F, Ridolfi C, Angiolini M, Spaggiari P, Carnaghi C,

Keywords: pNEN,